91.42
price up icon0.93%   0.84
after-market Dopo l'orario di chiusura: 91.48 0.06 +0.07%
loading
Precedente Chiudi:
$90.58
Aprire:
$91.87
Volume 24 ore:
2.08M
Relative Volume:
1.28
Capitalizzazione di mercato:
$45.22B
Reddito:
$9.91B
Utile/perdita netta:
$1.02B
Rapporto P/E:
44.60
EPS:
2.05
Flusso di cassa netto:
$665.00M
1 W Prestazione:
+10.30%
1M Prestazione:
+2.77%
6M Prestazione:
-5.37%
1 anno Prestazione:
+12.74%
Intervallo 1D:
Value
$91.05
$92.26
Intervallo di 1 settimana:
Value
$82.47
$92.26
Portata 52W:
Value
$77.54
$101.10

Alcon Inc Stock (ALC) Company Profile

Name
Nome
Alcon Inc
Name
Telefono
-
Name
Indirizzo
-
Name
Dipendente
25,599
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-12
Name
Ultimi documenti SEC
Name
ALC's Discussions on Twitter

Confronta ALC con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Medical Instruments & Supplies icon
ALC
Alcon Inc
91.42 45.22B 9.91B 1.02B 665.00M 2.05
Medical Instruments & Supplies icon
ISRG
Intuitive Surgical Inc
488.27 174.93B 8.35B 2.32B 1.30B 6.41
Medical Instruments & Supplies icon
BDX
Becton Dickinson Co
202.04 58.01B 20.64B 1.73B 2.94B 6.02
Medical Instruments & Supplies icon
RMD
Resmed Inc
213.97 31.43B 4.93B 1.25B 1.38B 8.47
Medical Instruments & Supplies icon
COO
The Cooper Companies, Inc.
77.80 15.49B 3.90B 392.30M 288.10M 1.95

Alcon Inc Stock (ALC) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-03-28 Reiterato Needham Buy
2025-03-25 Aggiornamento BofA Securities Neutral → Buy
2025-01-24 Reiterato Needham Buy
2025-01-10 Aggiornamento Redburn Atlantic Neutral → Buy
2024-12-17 Reiterato Needham Buy
2024-11-12 Reiterato Needham Buy
2024-10-10 Aggiornamento Redburn Atlantic Sell → Neutral
2024-09-10 Aggiornamento RBC Capital Mkts Sector Perform → Outperform
2024-07-15 Aggiornamento Morgan Stanley Underweight → Equal-Weight
2024-05-15 Aggiornamento Oppenheimer Perform → Outperform
2024-04-10 Iniziato Goldman Buy
2024-03-14 Iniziato RBC Capital Mkts Sector Perform
2024-02-06 Ripresa KeyBanc Capital Markets Overweight
2024-01-23 Iniziato Bernstein Outperform
2023-12-18 Downgrade Redburn Atlantic Neutral → Sell
2023-12-12 Iniziato Stifel Buy
2023-12-04 Downgrade Morgan Stanley Equal-Weight → Underweight
2023-08-17 Aggiornamento JP Morgan Neutral → Overweight
2023-05-30 Ripresa Morgan Stanley Equal-Weight
2023-05-10 Aggiornamento Robert W. Baird Neutral → Outperform
2023-03-01 Aggiornamento Societe Generale Sell → Hold
2022-12-22 Iniziato Mizuho Buy
2022-11-17 Downgrade Societe Generale Hold → Sell
2022-08-11 Downgrade Societe Generale Buy → Hold
2022-05-13 Ripresa Credit Suisse Outperform
2022-05-12 Aggiornamento Stephens Equal-Weight → Overweight
2022-04-08 Iniziato Needham Buy
2022-03-11 Iniziato BofA Securities Buy
2022-01-18 Downgrade Stephens Overweight → Equal-Weight
2022-01-07 Downgrade Morgan Stanley Overweight → Equal-Weight
2021-10-01 Iniziato Oppenheimer Perform
2021-07-14 Iniziato Deutsche Bank Buy
2021-05-06 Aggiornamento Citigroup Sell → Neutral
2021-03-22 Aggiornamento BTIG Research Neutral → Buy
2020-11-12 Downgrade Guggenheim Buy → Neutral
2020-07-06 Downgrade Citigroup Neutral → Sell
2020-07-06 Iniziato KeyBanc Capital Markets Sector Weight
2020-06-16 Aggiornamento Guggenheim Neutral → Buy
2020-04-08 Downgrade Robert W. Baird Outperform → Neutral
2020-03-26 Aggiornamento Argus Hold → Buy
2020-03-24 Aggiornamento Societe Generale Sell → Hold
2020-03-13 Aggiornamento UBS Neutral → Buy
2020-03-05 Iniziato Citigroup Neutral
2020-02-26 Aggiornamento Berenberg Hold → Buy
2020-01-08 Iniziato Argus Hold
2019-10-29 Iniziato Stephens Equal-Weight
2019-08-21 Reiterato BofA/Merrill Neutral
2019-06-24 Iniziato SVB Leerink Mkt Perform
2019-06-14 Iniziato BTIG Research Neutral
2019-05-10 Iniziato Robert W. Baird Outperform
2019-05-02 Iniziato Credit Suisse Outperform
Mostra tutto

Alcon Inc Borsa (ALC) Ultime notizie

pulisher
02:46 AM

Aniridia Treatment Market Is Going to Boom | Major Giants Alcon, Santen Pharmaceutical, Johnson & Johnson Vision - openPR.com

02:46 AM
pulisher
12:11 PM

There's Been No Shortage Of Growth Recently For Alcon's (VTX:ALC) Returns On Capital - Yahoo Finance

12:11 PM
pulisher
Apr 14, 2025

Alcon lines up product launches in India, bets on rising demand for advanced eye care - MSN

Apr 14, 2025
pulisher
Apr 10, 2025

Alcon: A Clear Vision, But Fully Valued (NYSE:ALC) - Seeking Alpha

Apr 10, 2025
pulisher
Apr 09, 2025

GE HealthCare Hires Alcon Exec Jeannette Bankes as Patient Care Solutions CEO - Medical Product Outsourcing

Apr 09, 2025
pulisher
Apr 08, 2025

Ophthalmic Devices Market Set to Attain Valuation of US$ 83.33 Billion By 2033 | Astute Analytica - GlobeNewswire Inc.

Apr 08, 2025
pulisher
Apr 08, 2025

Here’s Why ClearBridge Large Cap Growth Strategy Sold Alcon (ALC) - Insider Monkey

Apr 08, 2025
pulisher
Apr 08, 2025

Tesla, Warner Bros fend off some claims in 'Blade Runner 2049' ad dispute - Reuters

Apr 08, 2025
pulisher
Apr 08, 2025

Alcon (VTX:ALC) Seems To Use Debt Quite Sensibly - simplywall.st

Apr 08, 2025
pulisher
Apr 07, 2025

Alcon Scoops Up Aurion Biotech With Intent of Advancing Ophthalmology Cell Therapy AURN001 - CGTLive®

Apr 07, 2025
pulisher
Apr 05, 2025

Bernstein raises Alcon stock price target to CHF99 from CHF97.50 - Investing.com Canada

Apr 05, 2025
pulisher
Apr 04, 2025

Alcon, Aurion Reach Accord in Dispute Over Public Offering - Bloomberg Law News

Apr 04, 2025
pulisher
Apr 04, 2025

Bernstein raises Alcon stock price target to CHF99 from CHF97.50 By Investing.com - Investing.com South Africa

Apr 04, 2025
pulisher
Apr 04, 2025

Dr. Jeffrey Martin of SightMD Becomes One of the First on Long Island to Implant the new Clareon® PanOptix® Pro Lens by Alcon - PRWeb

Apr 04, 2025
pulisher
Apr 04, 2025

Alcon Publishes Agenda for 2025 Annual General Meeting - Business Wire

Apr 04, 2025
pulisher
Apr 03, 2025

ALC Stock May Rise With the Introduction of PanOptix Pro in US - MSN

Apr 03, 2025
pulisher
Apr 02, 2025

Alcon Introduces Clareon PanOptix Pro Intraocular Lens - Medical Product Outsourcing

Apr 02, 2025
pulisher
Apr 02, 2025

Alcon Expands Leadership in IOL Innovation with Clareon PanOptix - GuruFocus

Apr 02, 2025
pulisher
Apr 02, 2025

Alcon Expands Leadership in IOL Innovation with Clareon PanOptix Pro, Delivering Best-in-Class Light Utilization and Less Light Scatter - Business Wire

Apr 02, 2025
pulisher
Apr 01, 2025

The Zacks Analyst Blog Highlights Alcon, Glaukos and Regeneron Pharmaceuticals - Yahoo Finance

Apr 01, 2025
pulisher
Apr 01, 2025

Dry Eye Disease Market Growth in Future Scope 2025-2032 | - openPR.com

Apr 01, 2025
pulisher
Mar 31, 2025

KeyBanc raises Alcon stock price target to $112 on growth outlook - Investing.com Canada

Mar 31, 2025
pulisher
Mar 31, 2025

KeyBanc raises Alcon stock price target to $112 on growth outlook By Investing.com - Investing.com South Africa

Mar 31, 2025
pulisher
Mar 31, 2025

3 Stocks to Watch in the Evolving Cell-Based Ophthalmic Therapy Space - TradingView

Mar 31, 2025
pulisher
Mar 31, 2025

Deutsche Bank lifts Alcon stock price target to CHF96 from CHF92 - Investing.com Canada

Mar 31, 2025
pulisher
Mar 31, 2025

Deutsche Bank lifts Alcon stock price target to CHF96 from CHF92 By Investing.com - Investing.com South Africa

Mar 31, 2025
pulisher
Mar 29, 2025

Alcon Stock Might Rise as Clareon Vivity IOL Secures CE Mark Approval - MSN

Mar 29, 2025
pulisher
Mar 29, 2025

Stifel maintains Alcon stock Buy rating, $100 target By Investing.com - Investing.com Australia

Mar 29, 2025
pulisher
Mar 28, 2025

Citi maintains Alcon stock Buy rating, CHF99.00 target By Investing.com - Investing.com South Africa

Mar 28, 2025
pulisher
Mar 28, 2025

Mizuho lifts Alcon stock price target to $120, maintains Outperform By Investing.com - Investing.com Canada

Mar 28, 2025
pulisher
Mar 28, 2025

Taxation With Representation: Norton Rose, Latham, Ashurst - Law360

Mar 28, 2025
pulisher
Mar 28, 2025

Oppenheimer Remains a Buy on Alcon (ALC) - The Globe and Mail

Mar 28, 2025
pulisher
Mar 28, 2025

Stifel maintains Alcon stock Buy rating, $100 target - Investing.com

Mar 28, 2025
pulisher
Mar 28, 2025

Alcon stock price target raised to $110 at Needham - Investing.com India

Mar 28, 2025
pulisher
Mar 28, 2025

Alcon stock price target raised to $110 at Needham By Investing.com - Investing.com Australia

Mar 28, 2025
pulisher
Mar 28, 2025

Alcon (ALC) Soars 6.0%: Is Further Upside Left in the Stock? - Yahoo Finance

Mar 28, 2025
pulisher
Mar 28, 2025

Mizuho lifts Alcon stock price target to $120, maintains Outperform - Investing.com

Mar 28, 2025
pulisher
Mar 28, 2025

Jefferies raises Alcon stock price target to $115, maintains Buy - Investing.com India

Mar 28, 2025
pulisher
Mar 28, 2025

Jefferies raises Alcon stock price target to $115, maintains Buy By Investing.com - Investing.com South Africa

Mar 28, 2025
pulisher
Mar 28, 2025

Citi maintains Alcon stock Buy rating, CHF99.00 target - Investing.com India

Mar 28, 2025
pulisher
Mar 28, 2025

Alcon (VTX:ALC) ascends 4.7% this week, taking five-year gains to 80% - Yahoo Finance

Mar 28, 2025
pulisher
Mar 28, 2025

Alcon Acquires Majority Interest in Aurion Biotech, Inc. to Advance Cell Therapy for Corneal Endothelial Disease - VisionMonday.com

Mar 28, 2025
pulisher
Mar 27, 2025

Alcon Inc’s Acquisition of LENSAR Inc - Global Legal Chronicle

Mar 27, 2025
pulisher
Mar 27, 2025

Alcon: Innovation, Commercial Excellence, and Robust Momentum Mark Successful Capital Markets Day - Morningstar

Mar 27, 2025
pulisher
Mar 27, 2025

Alcon's Future Looks Fruitful as New Innovation and Commercial Execution Spark Market Outperformance - Morningstar

Mar 27, 2025
pulisher
Mar 27, 2025

All eyes on ophthalmic cell therapy space as Alcon takes majority stake in Aurion - FirstWord Pharma

Mar 27, 2025

Alcon Inc Azioni (ALC) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
medical_instruments_supplies BDX
$202.04
price down icon 1.78%
medical_instruments_supplies RMD
$213.97
price down icon 0.26%
medical_instruments_supplies COO
$77.80
price down icon 1.22%
medical_instruments_supplies WST
$212.50
price down icon 0.08%
medical_instruments_supplies BAX
$27.80
price down icon 2.04%
Capitalizzazione:     |  Volume (24 ore):